BIIB

Biogen Inc (BIIB)

US
$ 120.37-2.27%

Price Chart

Key Statistics

Market Cap
$ 17.64B
P/E Ratio
11.89
Revenue (TTM)
$ 9.82B
Volume
1.48M
52W High
$ 238.00
52W Low
$ 110.04
Dividend Yield
0.00%
Beta
0.12

Technicals

50-Day MA
129.0672
200-Day MA
161.3457
52 Week High
238
52 Week Low
110.04

About BIIB

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Employees
7605
Headquarters
Cambridge, MA
CEO
Mr. Christopher A. Viehbacher

Latest News

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score
22.95
Percentile: 33.82
Environmental Risk Score
1.02
Percentile: 2
Social Risk Score
13.48
Percentile: 2
Governance Risk Score
7.45
Percentile: 2

Controversy Level

ESG data provided by Sustainalytics, Inc.

BIIB
Category Average
2Moderate Controversy Level
NoneSevere

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
CLIK
Click Holdings Limi...
$ 0.58
107.18
FL
Foot Locker Inc.
$ 23.88
85.55
KDLY
Kindly MD Inc. Comm...
$ 13.65
76.58
AYTU
Aytu BioPharma Inc....
$ 2.38
76.30
GRYP
Gryphon Digital Min...
$ 1.09
45.08

Top Losers

Symbol/Name
LTP
% Chg
IXHL
Incannex Healthcare...
$ 0.31
-55.69
LAZR
Luminar Technologie...
$ 3.93
-16.00
KLAC
KLA Corporation Com...
$ 683.81
-15.05
MLGO
MicroAlgo Inc. Ordi...
$ 1.79
-14.76
DKS
Dick's Sporting Goo...
$ 179.72
-14.27